Syngene International share price
You have to be logged in to add this to Watchlist.- ₹668.20(2.41%)June 16, 2025 09:07:15 AM IST
- NSE
- BSE
- Vol : 0.08K (NSE + BSE)Last 20 day avg : 764.64 K
Syngene International is trading 2.41% upper at Rs 668.20 as compared to its last closing price. Syngene International has been trading in the price range of 668.20 & 668.20. Syngene International has given -23.92% in this year & 1.09% in the last 5 days. Syngene International has TTM P/E ratio 58.75 as compared to the sector P/E of 71.25.There are 9 analysts who have initiated coverage on Syngene International. There are 2 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 3 analysts have given the stock a sell rating.The company posted a net profit of 183.30 Crores in its last quarter.Listed peers of Syngene International include J B Chemicals And Pharmaceutical (0.30%), Piramal Pharma (0.17%), Syngene International (2.41%).The Mutual Fund holding in Syngene International was at 17.86% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Syngene International was at 19.47% in 31 Mar 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Jun 16, 2025, 03:41 AM UTC
- Dividend YieldLower than industry0.19Annual dividends as a percentage of the stock price.
- P/BLower than historical values5.55The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values52.93Price-to-earnings ratio based on trailing 12-month earnings
- BetaMedium volatility0.91Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.12The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in March quarter by 11.03% from Rs 1018.00 crore to Rs 916.90 crore, year-on-year
The company's profit declined by 2.81% year-on-year during the March quarter, dropping from Rs 188.60 crore to Rs 183.30 crore- The debt to equity of the company is higher than the industry median
- Company can comfortably pay off its interest obligations with its earnings
- R1
- 665.60
- R2
- 684.70
- R3
- 698.30
- S1
- 632.90
- S2
- 619.30
- S3
- 600.20
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| J B Chemicals And Pharmaceutical | Moderately Bullish | 1,737.20 | 0.30 | 27,397.15 | 41.73 | 7.86 | 0.71 | 0.19 |
| Piramal Pharma | Bearish | 200.55 | 0.17 | 26,658.07 | 294.44 | 3.26 | 0.05 | 40.78 |
| Syngene International | Neutral | 668.20 | 2.41 | 26,924.41 | 55.62 | 5.55 | 0.19 | 8.65 |
| Eris Lifesciences | Bullish | 1,755.05 | -2.19 | 23,903.32 | 69.55 | 8.57 | 0.41 | 62.42 |
| Alembic Pharmaceuticals | Moderately Bullish | 999.30 | - | 19,690.25 | 34.28 | 3.78 | 1.10 | 0.90 |
- Promoter(s) holds a high stake in the company at 52.74%
- Promoter(s) have decreased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding has decreased by 1.18 percentage points from previous quarter
- Mutual Funds holding has increased by 2.46 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-04-23 | Audited Results & Final Dividend |
| 2025-01-23 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
| 2024-07-24 | Quarterly Results |
| 2024-04-24 | Audited Results & Final Dividend |
- IndustryBiotechnology & Drugs
- ISININE398R01022
- BSE Code539268
- NSE CodeSYNGENE
Syngene International is trading at 668.20 as on Mon Jun 16 2025 03:37:15. This is 2.41% upper as compared to its previous closing price of 652.50.
The market capitalization of Syngene International is 26924.41 Cr as on Mon Jun 16 2025 03:37:15.
The average broker rating on Syngene International is Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 3 analysts have given a buy rating
- 1 analysts have given a hold rating
- 3 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Syngene International is 960.00 whereas the 52 wk low is 598.55
Syngene International can be analyzed on the following key metrics -
- TTM P/E: 58.75
- Sector P/E: 71.25
- Dividend Yield: 0.19%
- D/E ratio: 0.12
Syngene International reported a net profit of 496.20 Cr in 2025.
The Mutual Fund Shareholding was 17.86% at the end of 31 Mar 2025.